IHS Chemical Week

People & Business :: M&A

DSM Completes Acquisition of Biomedical Company Kensey Nash

12:59 AM MDT | June 25, 2012 | Deepti Ramesh

DSM says it has completed the previously announced acquisition of biomedical company Kensey Nash (Exton, PA) for about $360 million, and it is now a an indirect wholly owned subsidiary of DSM. The acquisition was first announced last month and the tender offer to acquire all the outstanding shares of common stock of Kensey Nash concluded on June 18. The acquisition will strengthen and complement DSM’s biomedical business, one of the three emerging business areas of DSM, the company says. Kensey Nash is primarily focused on regenerative medicine utilizing...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa